In this study, we measured the serum titin/creatinine (Cr) ratios in 110 patients with dystrophinopathy and compared them between patients with DMD and BMD with different clinical severities and unaffected controls to evaluate the discriminative ability of this measure. This evidence concerns the gene TTN and Duchenne muscular dystrophy.